Telemedicine, capable of transcending the boundaries of time and space, has become an essential part of medical institutions' efforts to improve the quality of healthcare. Taipei...
In May 2024, French pharmaceutical giant Sanofi announced a three-way collaboration with Formation Bio and OpenAI to develop AI software for drug research.
The Biomedical Technology and Device Research Laboratories (BTDRL) of the Industrial Technology Research Institute (ITRI) has announced a strategic partnership agreement with major...
As the global Generative AI (GenAI) phenomenon continues, Taiwan's traditionally conservative Ministry of Health and Welfare (MOHW) is becoming proactive in pursuing its applications...
Taiwan's National Health Insurance Administration (NHIA), under the Ministry of Health and Welfare, has clinched a five-year partnership with Google, aiming to incorporate cloud and...
Amazon Web Services (AWS) has announced plans to build regional data center operations in Taiwan, making Taiwanese Cloud Service Providers (CSPs) optimistic about the long-term imp...
Despite global expectations, Germany and the European Union have trailed in the race for digital healthcare, a surprising development compared to Taiwan's advancements.
Samsung Galaxy Ring, slated for potential release in the latter half of 2024, is expected to integrate with the company's AI-powered custom recipe platform, Samsung Food.
Qisda's strongest growth momentum comes from its healthcare business as revenue from the sector is expected to surpass NT$30 billion (US$947.75 million).
Qisda Chairperson Peter Chen announced that the group will be picking up its merger and acquisition pace this year, as several of its subsidiaries are slated for IPO and the conglomerate...
Tech industry leaders gathered at the Institute for Biotechnology and Medicine Industry's (IBMI) annual conference to offer their perspectives on AI-equipped smart medical services...
The Qisda Group is actively expanding its healthcare business, with revenue from the sector surpassing NT$20 billion (US$638.29 million) in 2023. Given the potential for the healthcare...